Related Experiment Videos
New challenges in infectious diseases
1Auckland Hospital.
Abstract:
Predicting the behaviour of infectious disease is particularly difficult because it is inextricably linked with microbial mutation and the potentially rapid expression of that change. Nevertheless, the dominant issue in infectious disease in New Zealand into the 1990s, and perhaps in all medicine, is the impact of the spread of HIV infection. Many other new agents and new causes for old familiar syndromes have also been unearthed in recent years and will continue to be so. We need to continue to explore aetiology, mechanisms of prevention and treatment for both the old and the new infectious diseases. Optimal vaccine delivery to those who most need it is a continuing challenge. New vaccines coming will complicate this. In treatment there has been a refreshing shift from chemotherapy to alternative approaches, perhaps summarised as attempts to enhance host immunity. All these treatments will need to be evaluated, and potentially uncomfortable cost benefit decisions made about the relative needs of all these competing costs in our health service. There are enormous research implications in this for basic scientists, laboratory microbiologists, infectious disease physicians and those in community health.
Insights
Predicting infectious disease spread, including HIV, is complex due to microbial mutation. Research must focus on new and old diseases, optimizing vaccine delivery and exploring host immunity treatments.
Area of Science:
- Medical Microbiology
- Epidemiology
- Public Health
Background:
- Infectious disease prediction is challenging due to microbial mutation and rapid genetic expression.
- The spread of Human Immunodeficiency Virus (HIV) has been a dominant issue in infectious disease in New Zealand since the 1990s.
- Emerging infectious agents and novel causes for established syndromes present ongoing public health concerns.
Purpose of the Study:
- To highlight the complexities in predicting infectious disease behavior.
- To emphasize the need for continued research into the etiology, prevention, and treatment of both established and emerging infectious diseases.
- To discuss challenges in optimal vaccine delivery and the evaluation of novel treatment strategies.
Main Methods:
- Review of current challenges in infectious disease management.
- Discussion of the impact of microbial mutation and HIV spread.
- Exploration of emerging trends in treatment, focusing on host immunity enhancement.
Main Results:
- The unpredictable nature of microbial mutation complicates disease forecasting.
- Human Immunodeficiency Virus (HIV) remains a significant public health challenge.
- A shift towards host immunity enhancement in treatment requires careful evaluation and cost-benefit analysis.
Conclusions:
- Continued research into etiology, prevention, and treatment is crucial for managing infectious diseases.
- Optimizing vaccine delivery and evaluating new immunotherapies are key challenges.
- Infectious disease research has broad implications for basic science, clinical practice, and public health policy.